Varicella-zoster immune globulin (VZIG) is a medication used for postexposure prophylaxis and treatment of varicella. It is in the "Opportunistic Infections and Co-infections" treatment class of drugs. Varicella-zoster immune globulin is indicated for post-exposure prophylaxis in high-risk individuals. This activity reviews the indications, contraindications, mechanism of action, adverse effects, and other vital elements of varicella-zoster immune globulin therapy in the clinical setting. It relates to the essential points needed by members of an interprofessional team managing high-risk individuals and prevents them against varicella and its related conditions.

**Objectives:**
- Identify the indications for varicella-zoster immune globulin.
- Describe the contraindications of varicella-zoster immune globulin.
- Review appropriate monitoring of varicella-zoster immune globulin.
- Summarize interprofessional team strategies for improving care coordination and communication about varicella-zoster immune globulin to advance and improve outcomes in susceptible patient populations.